Tag: interleukin-2

Natural immunity vs. Pfizer BNT162b2 vs. Coronavac

Posted on by Jesse Santiano, M.D.

The study, Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong, was published in the peer-reviewed journal Respirology. The two injections are different. The Pfizer BNT162b2  uses the modified RNA technology enclosed in a lipid nanoparticle. In contrast, the Coronavac uses an old vaccine technology using inactivated viruses that cannot replicate…

T cells from prior coronavirus protects and nucleocapsid directed COVID-19 shots may work better

Posted on by Jesse Santiano, M.D.

This article highlights a peer-reviewed study from the Imperial College of London. [1] The research answers the question, Why is it that not all people exposed to SARS-CoV-2 develop the disease? Is it possible that a previous illness from another coronavirus can protect against the SARS-CoV-2 virus? Is there a better alternative to spike-based vaccines?…